StockNews.AI
TWST
StockNews.AI
208 days

Gene Synthesis Market Size to Surpass USD 9.54 Billion by 2033 | Straits Research

1. Gene synthesis market projected to grow from $2.55B in 2025 to $9.54B by 2033. 2. Rising demand for personalized medicine positively impacts gene synthesis market growth. 3. North America leads in gene synthesis market due to major players and investments. 4. Twist Bioscience expanding antibody discovery capabilities to capitalize on market growth. 5. Government funding supports academic research, boosting gene synthesis services demand.

8m saved
Insight
Article

FAQ

Why Bullish?

The projected growth in the gene synthesis market indicates increased demand for Twist Bioscience's offerings.

How important is it?

The article discusses the growing market relevance of gene synthesis, directly impacting TWST's operations.

Why Long Term?

Positive market trends expected to drive sustained growth for TWST over coming years.

Related Companies

TWSTGENEWIZThermo Fisher Scientific
New York, United States, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Gene synthesis is a synthetic biology technique used in the laboratory to create artificial genes. In contrast to molecular cloning and polymerase chain reactions, this method uses solid-phase DNA synthesis (PCR). Gene synthesis is utilized for molecular cloning, the production of fusion proteins, and attaining sufficient protein expression levels. Compared to conventional molecular cloning techniques, the gene synthesis service provides unparalleled customization from top to bottom while saving time and money. Gene synthesis is the chemical in vitro synthesis of double-stranded DNA molecules. It is a biotechnology tool that has a significant impact on synthetic biology. Download Free Sample Report PDF @ https://straitsresearch.com/report/gene-synthesis-market/request-sample Market Dynamics Growing Adoption of Gene Therapy Techniques in Molecular Biology and Latest Developments in the Gene Synthesis Process Drive the Global Market In molecular biology and gene therapy, the development and application of numerous cutting-edge gene-editing techniques represent a significant advancement. Consequently, significant progress has been made in developing gene therapy for use in molecular biology. Recent technological advancements have produced well-designed goods and services, such as molecular separation, gene synthesis on microchips, and protein purification, which have contributed to the expansion of life science research. Gene synthesis has been acknowledged as an efficient and cost-effective alternative to conventional cloning and mutagenesis techniques. These dependable and efficient solutions in developed nations drive federal funding for various academic research projects and the market. Growing Population with Genetic and Chronic Disorders Creates Tremendous Opportunities One of the factors that will positively impact the gene synthesis market is the rising public demand for targeted and personalized medicine. In addition, increasing government, private, and public investment in synthetic biology is anticipated to speed up the global gene synthesis market and create lucrative business opportunities for key players in the coming years. Regional Analysis North America is the largest global gene synthesis market shareholder due to significant players and government initiatives in training and implementing synthetic biology programs. The increasing use of gene editing and synthesis-related techniques by drug and diagnostic developers in the United States fosters regional market expansion. Additionally, regulatory approval and commercialization of synthetic gene products in the region have contributed to the expansion of the market.  Ask for Customization @ https://straitsresearch.com/report/gene-synthesis-market/request-sample Key Highlights The global gene synthesis market size was valued at USD 2.20 billion in 2024 and is projected to reach from USD 2.55 billion in 2025 to USD 9.54 billion by 2033, growing at a CAGR of 15.8% during the forecast period (2025-2033).Based on the method, the market is divided into solid-phase, chip-based, and PCR-based enzyme synthesis. The solid-phase segment accounts for the largest revenue share due to the highest adoption rate over the past few years.Based on service, the market is categorized into antibody DNA synthesis, viral DNA synthesis, and others. The antibody DNA synthesis segment is the most dominant due to the large number of market participants providing services for antibody DNA synthesis.Based on application, the market is bifurcated into gene and cell therapy development, vaccine development, disease diagnosis, and others. The development of gene and cell therapies accounted for the largest revenue shareBased on end-user, the market is segmented into biotechnology and pharmaceutical companies, academic and government research institutes, and contract research organizations. The academic and governmental research institutes segment is anticipated to dominate the market.North America is the largest global gene synthesis market shareholder due to significant players and government initiatives in training and implementing synthetic biology programs. Competitive Players GenScriptBrooks Automation, Inc. (GENEWIZ)Boster Biological TechnologyTwist BioscienceProteoGenixBiomatikProMab Biotechnologies, Inc.Thermo Fisher Scientific, Inc.Integrated DNA Technologies, Inc.OriGene Technologies, Inc. Recent Developments June 2022- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Ildong Pharmaceutical announced an agreement under which Ildong will license a suite of Twist VHH antibody libraries to use to discover and develop antibodies for applications in immuno-oncology.July 2022- Twist Bioscience Opened New Twist Boston Location to Expand Antibody Discovery Capacity. Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced the opening of its new Twist Boston location in Quincy, Massachusetts. Segmentation By Method  Solid-phase SynthesisChip-based SynthesisPCR-based Enzyme Synthesis By Service Antibody DNA SynthesisViral DNA SynthesisOthers By Application  Gene and Cell Therapy DevelopmentVaccine DevelopmentDisease DiagnosisOthers By End-User Biotechnology and Pharmaceutical CompaniesAcademic and Government Research InstitutesContract Research Organizations By Region North AmericaEuropeAsia PacificMiddle East And AfricaLatin America Get Detailed Market Segmentation @ https://straitsresearch.com/report/gene-synthesis-market/segmentationAbout Straits Research Pvt. Ltd.Straits Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI. Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches. Phone: +1 646 905 0080 (U.S.) +44 203 695 0070 (U.K.) Email: sales@straitsresearch.com Follow Us: LinkedIn | Facebook | Instagram | Twitter

Related News